Fluconazole resistance in cryptococcal disease: emerging or intrinsic? (Q38044487)

27 August 2017

Fluconazole resistance in cryptococcal disease: emerging or intrinsic? (English)

1 reference

27 August 2017

1 reference

Jenny Wan Sai Cheong

1

1 reference

PubMed ID

22989195

27 August 2017

Joe McCormack

series ordinal

2

1 reference

27 August 2017

19 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

51

1 reference

27 August 2017

3

1 reference

27 August 2017

261-269

1 reference

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

27 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Successful public/private donation programs: a review of the Diflucan Partnership Program in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Process analysis of variables for standardization of antifungal susceptibility testing of nonfermentative yeasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Antifungal susceptibility testing: practical aspects and current challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Heteroresistance of Cryptococcus gattii to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Fulminant cryptococcal infections in HIV-infected patients on oral fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Cryptococcus neoformans var neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2012.715763

10.3109/13693786.2012.715763

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22989195